Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study

IMPORTANCE: Innovative anticancer therapies for children, adolescents, and young adults are regularly prescribed outside their marketing authorization or through compassionate use programs. However, no clinical data of these prescriptions is systematically collected. OBJECTIVES: To measure the feasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Berlanga, Pablo, Ndounga-Diakou, Lee Aymar, Aerts, Isabelle, Corradini, Nadège, Ducassou, Stéphane, Strullu, Marion, de Carli, Emilie, André, Nicolas, Entz-Werle, Natacha, Raimbault, Sandra, Roumy, Marianne, Renouard, Marjolaine, Gueguen, Gwenaelle, Plantaz, Dominique, Reguerre, Yves, Cleirec, Morgane, Petit, Arnaud, Puiseux, Chloe, Andry, Leslie, Klein, Sébastien, Bodet, Damien, Kanold, Justyna, Briandet, Claire, Halfon-Domenech, Carine, Nelken, Brigitte, Piguet, Christophe, Saumet, Laure, Chastagner, Pascal, Benadiba, Joy, Millot, Frédéric, Pluchart, Claire, Schneider, Pascale, Thouvenin, Sandrine, Gambart, Marion, Serre, Jill, Abbou, Samuel, Leruste, Amaury, Cayzac, Hélena, Gandemer, Virginie, Laghouati, Salim, Vassal, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318477/
https://www.ncbi.nlm.nih.gov/pubmed/37399010
http://dx.doi.org/10.1001/jamanetworkopen.2023.21568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318477/
https://www.ncbi.nlm.nih.gov/pubmed/37399010
http://dx.doi.org/10.1001/jamanetworkopen.2023.21568

Ejemplares similares